Document is current
Any future updates will be listed below
-
Authors
Dineen, Sean https://orcid.org/0000-0002-2012-2238
O’Leary, Charlotte
Rajasekhara, Sahana
Mullinax, John
- License Information
-
More Information
Article History
Received: 24 May 2025
Accepted: 6 August 2025
First Online: 23 August 2025
Disclosures
: Sean Dineen has received consulting fees from Oncoinvent for activities not related to this manuscript. John Mullinax has participated in sponsored research agreements with Iovance Biotherapeutics, Intellia Therapeutics, and SQZ Biotech; has received research support from the following entities: NIH-NCI (K08CA252642), Ocala Royal Dames, and V Foundation; and has received ad hoc consulting fees from Merit Medical, Lyell Immunopharma, and Iovance Biotherapeutics. Moffitt Cancer Center has licensed Intellectual Property (IP) related to the proliferation and expansion of tumor-infiltrating lymphocytes to Iovance Biotherapeutics. John Mullinax is an inventor on such Intellectual Property. Charlotte O’Leary and Sahana Rajasekhara have no conflicts of interest to declare that may be relevant to the contents of this article.
